Trial Profile
Phase I/II trial of STC101 for the treatment of cancer
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 04 Jun 2015
Price :
$35
*
At a glance
- Drugs Trastuzumab (Primary)
- Indications Cancer
- Focus Adverse reactions
- 04 Jun 2015 New trial record